Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of treating moderately to severely active ulcerative colitis by administering an anti-IL12/IL23 antibody

Methods of treating moderately to severely active ulcerative colitis by administering an anti-IL12/IL23 antibody

US Patent 10961307 · Granted Mar 30, 2021

Estimated economic value: $81,035,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Nucleic acid, composition and conjugate comprising the same, preparation method 2025
Nucleic acid, composition and conjugate containing same, preparation method, and2025
Method of treating inflammatory bowel disease with a combination therapy of anti2025
Methods of treating Crohn's disease with anti-IL23 specific antibody2024
Nucleic acid, composition and conjugate comprising the same, and preparation met2024
Nucleic acid, composition and conjugate comprising the same, and preparation met2024
Nucleic acid, pharmaceutical composition and conjugate containing nucleic acid, 2024
SiRNA conjugate, preparation method therefor and use thereof2024
Method of treating inflammatory bowel disease with a combination therapy of anti2023
Nucleic acid, composition and conjugate containing same, preparation method, and2023
Methods for the administration of certain VMAT2 inhibitors2023
Conjugates and preparation and use thereof2023